Primary progressive multiple sclerosis: part of the MS disease spectrum or separate disease entity?

Area of Science:

• Neurology
• Immunology
• Demyelinating Diseases

Background:

• Multiple sclerosis (MS) is the most common demyelinating disease with heterogeneous clinical presentations.
• Most patients begin with relapsing-remitting MS (RRMS), with a significant proportion progressing to secondary progressive MS (SPMS).
• Primary progressive MS (PPMS) affects about 15% of patients from disease onset, with unknown underlying pathogenic mechanisms.

Purpose of the Study:

• To review and summarize current knowledge on the clinical, epidemiological, imaging, and pathological features of PPMS.
• To compare the characteristics of PPMS with those of RRMS and SPMS.
• To explore the potential spectrum of MS disease courses influenced by genetic and environmental factors.

Main Methods:

• Literature review summarizing existing research on multiple sclerosis disease courses.
• Comparative analysis of clinical, epidemiological, imaging, and pathological data for PPMS, RRMS, and SPMS.
• Discussion of genetic predisposition and environmental influences on MS phenotypes.

Main Results:

• PPMS and SPMS share similarities in imaging and pathology, with differences being quantitative rather than qualitative.
• PPMS patients lack a female predominance and typically have a later onset compared to RRMS patients.
• Discordance in disease course among monozygous twins suggests multifactorial etiology beyond genetics.

Conclusions:

• The distinct MS disease courses may represent a spectrum modulated by genetic and environmental factors.
• Further research into the pathogenic mechanisms of PPMS is needed.
• Understanding the similarities and differences between PPMS, RRMS, and SPMS is crucial for patient management and therapeutic development.